Science Explorer Back to mapMap
Discussion
Researcher · Simcere Pharmaceutical (China) · China

Yingxue Qi

Yingxue Qi publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Cancer Research, on topics such as Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics and Cancer Immunotherapy and Biomarkers.

OpenAlex
World rank
#3,515,437
of 7,710,434 ranked researchers
Rank in China
#551,055
of 978,568
Works
40
Citations
206
Citations per work
5.2
h-index
8
i10-index 6Top 64% in Pulmonary and Respiratory Medicine
Yingxue Qi

What does Yingxue Qi research?

Yingxue Qi's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (4%).

Health Sciences: 22 works · 54.6% of their workMedicine: 22 works · 54.6% of their workPulmonary and Respiratory Medicine: 12 works · 29.6% of their workOncology: 9 works · 21.3% of their workGenetics: 1 works · 3.7% of their workLife Sciences: 10 works · 24.1% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 20.4% of their workCancer Research: 7 works · 16.7% of their workMolecular Biology: 1 works · 3.7% of their workImmunology and Microbiology: 1 works · 3.7% of their workImmunology: 1 works · 3.7% of their workEverything else: 9 works · 21.3% of their workTHEIR WORKYingxue Qi40works
Life Sciences24%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2254.6%
    1. Biochemistry, Genetics and Molecular Biology820.4%
    2. Immunology and Microbiology13.7%
  3. Everything else921.3%
  1. 1Pulmonary and Respiratory Medicine30% of their works
  2. 2Oncology21% of their works
  3. 3Cancer Research17% of their works
  4. 4Genetics4% of their works
  5. 5Molecular Biology4% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Yingxue Qi's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, ALK Inhibitors, EGFR Mutations, Cancer Genomics, Mutational Signatures, Tumor Microenvironment and Radiotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Targeted Therapy363 topics
  2. Clinical Trials222 topics
  3. ALK Inhibitors171 topic
  4. EGFR Mutations171 topic
  5. Cancer Genomics141 topic
  6. Mutational Signatures141 topic
  7. Tumor Microenvironment132 topics
  8. Radiotherapy123 topics
  9. Chemotherapy102 topics
  10. Immune Checkpoint Blockade91 topic
  11. Immunotherapy92 topics
  12. PD-1 and PD-L191 topic
  13. Gene Expression72 topics
  14. CT Screening51 topic
  15. Genomic Profiles51 topic
  16. Lung Cancer51 topic
  17. Small-Cell Lung Cancer51 topic
  18. Cancer41 topic
  19. Ferroptosis41 topic
  20. Glioblastoma41 topic
  21. Temozolomide41 topic
  22. Breast Tumours31 topic
  23. Treatment Response31 topic

Where does Yingxue Qi work?

Yingxue Qi's main affiliation in the publication record is Simcere Pharmaceutical (China), China.

How many publications and citations does Yingxue Qi have?

OpenAlex counts 40 works and 206 citations for Yingxue Qi, an h-index of 8, ranking #3,515,437 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Yingxue Qi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.